The growing practice of consuming 5MeO dimethyltryptamine in Canada presents significant risks and complex statutory concerns. Currently, 5meo dimethyltryptamine remains a Schedule One substance under the CDSA, making its holding and sale illegal. While ingestion delivers the chemical swiftly, it